AbbVie (ABBV) Return on Capital Employed [ROCE] (2013 - 2026)
AbbVie's Return on Capital Employed [ROCE] was 21.60% in Q3 2026, up 12.20 percentage points from 9.40% a year earlier and up 3.68 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at AbbVie came in at 16.52%, up 7.02 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a five-year change of +4.05 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was 9.50% in FY2024 (-3.40 pp), 12.90% in FY2023 (-3.12 pp), 16.01% in FY2022 (+0.20 pp) and 15.81% in FY2021 (+3.35 pp).
- The Q3 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q4 2019.
- Compared with a year earlier, Return on Capital Employed [ROCE] has increased for four straight quarters, with an average year-over-year change of +2.63 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2026 (a gain of 12.20 percentage points); the worst was Q2 2024 (a drop of 5.07 percentage points).
- Per Business Quant data, ABBV's Return on Capital Employed [ROCE] in the three quarters before Q3 2026 was 17.92% (Q2 2026), 16.47% (Q1 2026) and 16.63% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 17.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.60% |
| Jun 30, 2026 | 17.92% |
| Mar 31, 2026 | 16.47% |
| Dec 31, 2025 | 16.63% |
| Sep 30, 2025 | 9.40% |
| Jun 30, 2025 | 11.32% |
| Mar 31, 2025 | 10.15% |
| Dec 31, 2024 | 9.09% |
| Sep 30, 2024 | 13.88% |
| Jun 30, 2024 | 11.86% |
| Mar 31, 2024 | 12.75% |
| Dec 31, 2023 | 13.07% |
| Sep 30, 2023 | 14.91% |
| Jun 30, 2023 | 16.93% |
| Mar 31, 2023 | 14.82% |
| Dec 31, 2022 | 16.39% |
| Sep 30, 2022 | 16.15% |
| Jun 30, 2022 | 16.00% |
| Mar 31, 2022 | 16.50% |
| Dec 31, 2021 | 15.93% |
API Access
AbbVie Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();